New York Court Dismisses Tara Moore's $20m Claim Against the WTA
**Câu trả lời cốt lõi:** Tòa án Quận Hoa Kỳ tại New York đã bác đơn kiện của tay vợt đôi người Anh Tara Moore, người đòi 15 triệu bảng (khoảng 20 triệu USD) từ WTA liên quan tới án cấm thi đấu bốn năm sau mẫu dương tính nandrolone tại Colombia năm 2022. Tòa chỉ thị đóng hồ sơ vụ việc. **Dữ kiện chính:** - Tara Moore, 34 tuổi, tay vợt đôi người Anh, bị cấm thi đấu bốn năm sau mẫu dương tính nandrolone thu tại giải WTA ở Bogotá, Colombia, tháng 4 năm 2022. - Đơn kiện đòi 15 triệu bảng Anh, tương đương khoảng 20 triệu USD, tiền bồi thường từ WTA. - Lập luận trung tâm: WTA không cảnh báo tay vợt về rủi ro thực phẩm nhiễm độc tại giải đấu ở Colombia. - Tòa án Quận Hoa Kỳ tại New York bác đơn kiện và chỉ thị đóng vụ việc. - Moore nói với BBC Sport vụ việc là “một cơn ác mộng” và hệ thống phòng chống doping quần vợt “đã hỏng”. **Nguồn:** BBC Sport — bản tin về phán quyết của Tòa án Quận Hoa Kỳ tại New York, công bố tháng 8 năm 2026 | Cross-checked: VuaBong.vn **Hỏi đáp liên quan:** Q: WTA có trực tiếp xử lý các vụ doping quần vợt không? A: Không, Chương trình Phòng chống Doping Quần vợt do ITIA vận hành dưới quyền đồng thuận của ATP, WTA, ITF và Ban Grand Slam. Q: Quần vợt từng có tiền lệ nào về lập luận nhiễm chéo thực phẩm? A: Robert Farah dương tính boldenone tại Wimbledon 2019 và được xóa án năm 2020 sau khi hội đồng độc lập chấp nhận nguồn thực phẩm Colombia. Q: Bước tiếp theo của vụ việc là gì? A: Moore có thể kháng cáo lên cấp phúc thẩm liên bang Hoa Kỳ và dựng lại lập luận ở tầng nghĩa vụ cảnh báo.
In April 2026, in Bogotá — a city sitting 2,640 metres above sea level — Tara Moore left a urine sample after a match at a WTA event in Colombia. That sample contained 19-norandrosterone, the metabolite of nandrolone. What followed was a four-year ban, a frozen doubles career, and a lawsuit claiming £15m — roughly $20m — in damages. This week, a federal court in New York dismissed the claim and directed that the matter be closed.
Moore told BBC Sport the case has been “a nightmare,” and that it “shows how broken the anti-doping system is in tennis.”
I re-read the full chain of evidence the way I always handle doping files: timeline first, numbers second, verdict last. What was dismissed sits at the level of legal duty; the meat itself remains an open technical question that a civil court never reached. That is where the spreadsheet starts talking.

Context: one sample, four layers of institutions
Moore competed professionally in both singles and doubles, spending most of her career at ITF level, WTA 125s and a handful of WTA 250s — tiers whose total prize money often falls short of $300,000. According to WTA data, her career prize money has not passed the $1m mark. That number matters, and I will return to it, because it shapes how credible a $20m claim looks in a US courtroom.
The sequence, per the public record: a nandrolone positive sample collected at a tournament in Colombia; the International Tennis Integrity Agency (ITIA) announcing a provisional suspension; Moore denying intentional doping and building her defence on contaminated food. An independent tribunal accepted that argument and lifted the ban. The claimant side says the ITIA appealed to the Court of Arbitration for Sport (CAS), which imposed a four-year sanction. That sanction turned a doubles player into a legal file.
The lawsuit was filed in a US federal court, with one central argument: the WTA failed to warn players about the risk of contaminated food at the tournament held in Colombia. The United States District Court in New York disagreed and moved to close the matter.
The institutional architecture matters here, because it is the spine of the case. The Tennis Anti-Doping Programme is operated by the ITIA under the joint authority of four stakeholder groups: the ATP, the WTA, the International Tennis Federation (ITF) and the Grand Slam Board. WADA writes the Code and sets technical thresholds. Accredited laboratories analyse samples. CAS arbitrates disputes. The WTA is one of four co-owners of the programme and, separately, the organiser of tournaments. Those two roles do not carry the same legal duties.
Data is never in a hurry. It is people who rush, and people who get it wrong.
Core: the precedent file and the limits of a number
The clearest food-contamination precedent in men's tennis is Robert Farah. The Colombian doubles player — then world No 1 in doubles — returned a positive test for boldenone at Wimbledon 2026. He defended himself on the basis of food consumed in Colombia and was cleared by an independent tribunal in 2026. That file proves two contradictory things at once: the contaminated-food argument can succeed, and it only succeeds when the accused side can assemble a chain of evidence pointing to a specific food source.
This is the part I wanted to read closely, like a data table. In contamination cases, the two sides measure different things. The anti-doping body measures the concentration of a metabolite in urine against WADA's technical threshold — for 19-norandrosterone, that threshold sits in the nanograms-per-millilitre range. The athlete has to measure something no laboratory holds: the origin of a piece of meat, the timing of a meal, the portion, the brand, the processing plant, the supply chain. The error margin on the first measurement is a percentage. The error margin on the second is whatever evidence can or can never be collected.
The WADA Code leaves a door open: the “no fault or no significant fault” provision, which allows a sanction to be reduced or erased where an athlete proves the substance entered the body without fault. It is a narrow door, and the burden of proof sits entirely on the athlete. A positive sample is an objective fact. The cause of that positive sample is a story that must be proven.
Read the Code as a technical document and an arithmetic paradox appears: a four-year sanction in a case where a lower tribunal had already accepted contaminated food. The paradox is not about severity; it is about two levels of adjudication reading the same dataset and reaching opposite verdicts. When a dataset permits two opposite conclusions, the issue is no longer the number — it is the standard of proof at each level.
People remember results. I remember the conditions that produced them.

A US civil court reads a file on an entirely different logic. For a damages claim to survive an early stage, a plaintiff must show at least four components: a legal duty owed by the defendant, a breach of that duty, a causal link between breach and harm, and quantifiable harm. On the argument that “the WTA failed to warn about food risk,” the first three components wobble. Whether a duty to warn about food risk in a specific country exists in the legal relationship between a tour and a player is a question of law, not of fact. The New York court answered at the level of law.
On the damages component, the $20m figure deserves separate scrutiny. Moore's career prize money, per WTA data, has not passed $1m. To justify $20m, a plaintiff must produce a model of assumed earnings across lost years — prize money, sponsorship, licensing, playing opportunities. Such models exist, and they are always countered by a simple argument: the earnings of a doubles player at WTA 125 and WTA 250 level depend on ranking, calendar and form — three variables that cannot be proven by extrapolation.
Based on my experience tracking matches and disciplinary files, doping cases rarely win in civil court, and when they do win, they win somewhere else entirely — in a sports arbitration room, where the standard of proof is already written into the applicable rules. A civil court has no such framework. It has another one, and that one just closed at first instance.
The most notable thing about this ruling is not that it protects the WTA, but that it establishes something else: an athlete's loss can be real — measurable in years taken out of a career — and still find no entrance into the civil damages system.
Contrarian: a warning is not a duty
Suppose the WTA had taped a sheet of paper in the Bogotá locker room that week, cautioning players about local food. What would have changed in the final outcome?
The honest answer is: almost nothing. A positive sample is still a positive sample. The technical threshold is still applied under the Code. An independent tribunal still has to weigh evidence about the food source. And if CAS reads the file differently, the four-year sanction still stands. A warning sheet does not change the operating chain — it only changes how moral responsibility gets attributed.
This is where the legal argument hits a ceiling. The claimant chose a defendant whose name is on the tournament signage. But the decision-making chain sits with the ITIA, WADA and CAS. Suing the WTA means suing the programme's co-owner, not the rule-maker and the adjudicator. The distance between those entities is the entire case.
Every test sample is a hypothesis. The question is who carries the duty to verify it.
Here I have to draw the humility line: a dismissal that closes a matter does not establish whether the WTA warned players or not. The court stopped at the level of legal duty and never reached the level of fact. Anyone reading this ruling as a moral verdict on the WTA is reading more than the paper contains. I have no record confirming what the Bogotá organisers advised in 2026. Without evidence, I do not conclude.
And here is the most inconvenient part: for a player who earned under $1m across an entire career, the cost of pursuing a cross-border civil case in New York can consume most of that accumulated prize money. Legal cost is a figure that never appears on a scoreboard, yet it decides who can demand justice and who must stay silent. The anti-doping system is not free for athletes; it is simply paid for in advance.
Takeaway: signals to watch in the next round
Three signals sit on my watchlist. Whether Moore appeals to a federal appellate court and rebuilds her argument at the level of the duty to warn. Whether WADA and the ITIA draft risk-based dietary guidance by region — Colombia is the clearest example, but the list of destinations with hard-to-control food supply chains is far longer than one Bogotá tournament. And whether players begin asking tour medical departments for a food-risk brief before each swing, the way they already ask for information on surface and climate.
If a ranking list remains the only thing published widely, then losses that cannot be ranked will stay the one kind of data nobody is obliged to measure.
